Search:
Login:
OR

Marijuana Blog

First Medical Marijuana Dispensary in New Jersey Faces Delayed Opening

Category: Dispensaries | Posted on Mon, October, 1st 2012 by THCFinder

The opening of New Jersey's first state-authorized medical marijuana dispensary is going to be delayed, according to the New Jersey Department of Health.

 

Greenleaf Alternative Treatment Center will not be ready to open for several weeks because it does not have its final certificate of occupancy from Montclair Township, New Jersey.

 

Delays have been numerous for patients in New Jersey, and that, combined with the heavy restrictions in the program itself, makes one wonder just how serious officials in NJ are about helping sick people.

 

The New Jersey legislature passed a law allowing medical marijuana in January 2010, but no dispensaries have opened yet.

 

So far, 170 physicians and 239 patients have registered to take part in the program.

 

Check out the woman in the video below at about 1:20 in who talks about medical marijuana not being for anxiety since Xanax can be prescribed for that. Some people are just woefully unaware of the awful side effects that come with drugs like Xanax. The male reporter describes the cannabis user as “glassy” towards the end of the interview; have you ever seen someone after taking a Xanax?

 

 

Source: http://newyork.newsday.com


Comments
 
Comments


Recent Articles






Search







Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
Drive420.com - Daily SPECIALS!
21.3 Miles Away | Ventura thru TO,
OG California Herbal Remedies
7.7 Miles Away | Los Angeles,
Big Bud Farms
15.4 Miles Away | Anaheim,
What strain are you smoking on today?
May 6, 2016 | Category: Fun
California Marijuana Legalization Story
May 6, 2016 | Category: Legalization
Workaholics - Whose Weed is That
May 6, 2016 | Category: Videos
Mobile Apps
Copyright 2016 THCFinder.com
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us